MedTrace Logo

Newborn Sequencing Screening in China

NCT05476640 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3348

Last updated 2026-05-27

No results posted yet for this study

Summary

The project will carry out the genetic testing of 10000 neonates. The aim of the project is to assess the application of targeted sequencing technology in the screening of neonatal diseases.

Conditions

  • Newborns

Interventions

GENETIC

NGS

In the Nation multicenter screening cohort, NGS testing was performed on the basis of conventional NBS to study the relationship between gene variation and disease occurrence;

Sponsors & Collaborators

  • Xuzhou maternal and Child Health Care Hospital

    collaborator UNKNOWN

  • Northwest Women's and Children's Hospital, Xi'an, Shaanxi

    collaborator OTHER

  • Inner Mongolia Maternal and Child Health Care Hospital

    collaborator OTHER

  • Shanghai Children's Hospital

    lead OTHER

Principal Investigators

  • Lin Zou · Shanghai Children's Hospital

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-20
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476640 on ClinicalTrials.gov